Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study

Thrombosis Research

Volumn 126, Issue 5, 2010, Pages 373-378

  Barsoum, Michel K ^a   Heit, John A ^a   Ashrani, Aneel A ^a   Leibson, Cynthia L ^a   Petterson, Tanya M ^a   Bailey, Kent R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Deep vein thrombosis; Epidemiology; Progestin; Pulmonary embolism; Venous thromboembolism

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AMENORRHEA; ANOVULATION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HOSPITALIZATION; HUMAN; INJURY; LONGITUDINAL STUDY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; MENOPAUSAL SYNDROME; NURSING HOME; OUTCOME ASSESSMENT; PARESIS; POPULATION RESEARCH; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; VARICOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; ESTROGENS; FEMALE; HUMANS; LONGITUDINAL STUDIES; PROGESTINS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 78149283479     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.08.010     Document Type: Article

References (32)

1. P. Marcelo, V. Gomes, R. Steven, and M. Deitcher Risk of Venous Thromboembolic Disease Associated With Hormonal Contraceptives and Hormone Replacement Therapy. A Clinical Review Arch Intern Med 164 2004 1965 1975 (Reprinted 1965-1975)
2. C. Vasilakis, S. Jick, and H. Jick The risk of venous thromboembolism in users of postcoital contraceptive pills Contraception 59 1999 79 83
3. N. Poulter, C. Chang, T. Farley, and O. Meirik Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications Lancet 354 1999 1610
4. H. Jick, S. Jick, V. Gurewich, M. Myers, and C. Vasilakis Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components Lancet 346 1995 1589 1593
5. E. Daly, M. Vessey, M. Hawkins, J. Carson, P. Gough, and S. Marsh Risk of venous thromboembolism in users of hormone replacement therapy Lancet 348 1996 977 980
6. S. Perez Gutthann, L. Garcia Rodriguez, J. Castellsague, and A. Duque Oliart Hormone replacement therapy and risk of venous thromboembolism: population based case-control study Br Med J 314 1997 796 800
7. D. Grady, N. Wenger, D. Herrington, S. Khan, C. Furberg, and D. Hunninghake Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study Ann Intern Med 132 2000 689 696
8. Writing Group for the Women's Health Initiative Investigators Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Principal Results From the Women's Health Initiative Randomized Controlled Trial JAMA 288 2002 321 333
9. N. Smith, S. Heckbert, R. Lemaitre, AP. Reiner, T. Lumley, and NS. Weiss Esterified estrogens and conjugated equine estrogens and the risk for venous thrombosis JAMA 292 2004 1581 1587
10. M. Cushman, L. Kuller, R. Prentice, RJ. Rodabough, BM. Psaty, and RS. Stafford Estrogen plus progestin and risk of venous thrombosis JAMA 292 2004 1573 1580
11. J. Douketis, J. Julian, C. Kearon, DR. Anderson, MA. Crowther, and SM. Bates Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study J Thromb Haemost 3 2005 943 948
12. F. Grodstein, M. Stampfer, S. Goldhaber, JE. Manson, GA. Colditz, and FE. Speizer Prospective study of exogenous hormones and risk of pulmonary embolism in women Lancet 348 1996 983 987
13. The Women's Health Initiative Steering C The Women's Health Initiative Randomized Controlled Trial. Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy JAMA vol. 291 2004 1701 1712
14. D. Curb, R. Prentice, P. Bray, RD. Langer, L. Van Horn, and VM. Barnabei Venous thrombosis and conjugated equine estrogen in women without a uterus Arch Intern Med 2006 166
15. C. Vasilakis-Scaramozza, and H. Jick Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives Lancet 358 2001 1427 1429
16. A. van Hylckama Vlieg, F. Helmerhorst, J. Vandenbroucke, C. Doggen, and F. Rosendaal The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study Br Med J 339 2009 b2921
17. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Effect of different progestagens in low estrogen oral contraceptives on venous thromboembolic disease Lancet 346 1995 1582 1588
18. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study Lancet 346 1995 1575 1582
19. C. Straczek, E. Oger, M. Yon de Jonage-Canonico, G. Plu-Bureau, J. Conrad, and G. Meyer Estrogen and Thromboembolism Risk (ESTHER) Study Group. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration Circulation 112 2005 3495 3500
20. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study Contraception 57 1998 315 324
21. C. Vasilakis, H. Jick, and M. del Mar Melero-Montes Risk of idiopathic venous thromboembolism in users of progestagens alone Lancet 354 1999 1610 1611
22. L. Melton History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
23. M. Silverstein, J. Heit, D. Mohr, T. Petterson, W. O'Fallon, and L. Melton Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based, cohort study Arch Intern Med 158 1998 585 593
24. J. Heit Venous thromboembolism: disease burden, outcomes and risk factors. State of the Art J Thromb Haemost 3 2005 1611 1617
25. J. Heit, M. Silverstein, D. Mohr, T. Petterson, W. O'Fallon, and L. Melton Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 2000 809 815
26. J. Heit, C. Leibson, A. Ashrani, T. Petterson, K, Bailey, and LJ. Melton III Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study Arterioscler Thromb Vasc Biol 29 2009 1399 1405 131281
27. L. Kurland, and C. Molgaard The patient record in epidemiology Sci Am 245 1981 54 63
28. S. Jick, J. Kaye, S. Russmann, and H. Jick Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel Contraception 73 2006 566 570
29. S. Jick, J. Kaye, S. Russmann, and H. Jick Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol Contraception 73 2006 223 228
30. M. Thorogood, J. Mann, M. Murphy, and M. Vessey Risk factors for fatal venous thromboembolism in young women: a case-control study Int J Epidemiol 21 1992 48 52
31. M. Vickers, A. MacLennan, B. Lawton, D. Ford, J. Martin, and SK. Meredith Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women Br Med J 335 2007 239
32. O. Lidegaard, E. Lokkegaard, A. Svendsen, and C. Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study Br Med J 339 2009